Frontiers | Humoral and Cellular Immunogenicity and Safety of Five Different SARS-CoV-2 Vaccines in Patients With Autoimmune Rheumatic and Musculoskeletal Diseases in Remission or With Low Disease Activity and in Healthy Controls:
Gábor Kerecsen - Head of Invasive cardiology - MH EK Honvédkórház | LinkedIn